A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

INTRODUCTION: Semaglutide once-weekly (QW) is a novel glucagon-like peptide-1 (GLP-1) analogue administered at a 0.5 or 1.0 mg dose. In the absence of head-to-head trials between semaglutide QW and other GLP-1 receptor agonists (GLP-1 RAs) in a Japanese population, a network meta-analysis (NMA) was...

Descripción completa

Detalles Bibliográficos
Autores principales: Webb, Neil, Orme, Michelle, Witkowski, Michal, Nakanishi, Rie, Langer, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984907/
https://www.ncbi.nlm.nih.gov/pubmed/29574633
http://dx.doi.org/10.1007/s13300-018-0397-1

Ejemplares similares

Ejemplares similares